Year-End Sale is Live! Find Exclusive Prices on the Best Selling Pharma & MedTech Reports. Check Now!

Bipolar disorder

Oct 18, 2024

Schizophrenia vs Bipolar disorder: Biomarkers to the rescue

Apr 05, 2024

Vanda Broadens its Reach to Bipolar Disorder Treatment Market With Fanapt Approval

Dec 20, 2022

Fourth FDA Approval for AbbVie’s Vraylar; FDA Approves Ferring’s Adstiladrin for NMIBC; Merck and Moderna’s mRNA Cancer Vaccine Trial; EMA Recommends the CSL’s Gene Therapy for Hemophilia B; CHMP Backs Amicus’ Pompe Disease Therapy; Takeda Announces the Phase 3 AURORA Study Result

Apr 12, 2022

BioXcel’s Agitation Drug Igalmi; FDA Approves Cysteine Hydrochloride Injection; Gilead’s Trodelvy; Alembic Pharma’s Topical Anesthetic Cream; Pfizer Acquires ReViral; Telix Buys Lilly’s Failed Cancer Drug Lartruvo

Dec 01, 2021

Plotting the Extensive Demand of Mobile Apps for Mental Health

Mar 31, 2021

How Depression Is Eroding The Mental And The Physical Health Of The Society?

Dec 28, 2020

Watch Out For Top Pipeline Therapies Making An Impact In The Bipolar Depression Market

Dec 16, 2019

Increasing cases of Mania and Bipolar disorder market

Newsletter/Whitepaper